Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 6
2019 4
2020 6
2021 7
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study.
Verstovsek S, Gerds AT, Vannucchi AM, Al-Ali HK, Lavie D, Kuykendall AT, Grosicki S, Iurlo A, Goh YT, Lazaroiu MC, Egyed M, Fox ML, McLornan D, Perkins A, Yoon SS, Gupta V, Kiladjian JJ, Granacher N, Lee SE, Ocroteala L, Passamonti F, Harrison CN, Klencke BJ, Ro S, Donahue R, Kawashima J, Mesa R; MOMENTUM Study Investigators. Verstovsek S, et al. Lancet. 2023 Jan 28;401(10373):269-280. doi: 10.1016/S0140-6736(22)02036-0. Lancet. 2023. PMID: 36709073 Clinical Trial.
Perioperative Management of Sickle Cell Disease.
Adjepong KO, Otegbeye F, Adjepong YA. Adjepong KO, et al. Among authors: otegbeye f. Mediterr J Hematol Infect Dis. 2018 May 1;10(1):e2018032. doi: 10.4084/MJHID.2018.032. eCollection 2018. Mediterr J Hematol Infect Dis. 2018. PMID: 29755709 Free PMC article. Review.
Nomenclature for Cellular and Genetic Therapies: A Need for Standardization.
Sharma A, Farnia S, Otegbeye F, Rinkle A, Shah J, Shah NN, Gill S, Maus MV. Sharma A, et al. Among authors: otegbeye f. Transplant Cell Ther. 2022 Dec;28(12):795-801. doi: 10.1016/j.jtct.2022.08.029. Epub 2022 Sep 2. Transplant Cell Ther. 2022. PMID: 36058548 Free PMC article.
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia.
Metheny LL, Sobecks R, Cho C, Fu P, Margevicius S, Wang J, Ciarrone L, Kopp S, Convents RD, Majhail N, Caimi PF, Otegbeye F, Cooper BW, Gallogly M, Malek E, Tomlinson B, Gerds AT, Hamilton B, Giralt S, Perales MA, de Lima M. Metheny LL, et al. Among authors: otegbeye f. Blood Adv. 2024 Mar 26;8(6):1384-1391. doi: 10.1182/bloodadvances.2023011514. Blood Adv. 2024. PMID: 38170741 Free PMC article.
Socioeconomic Factors and Survival of Multiple Myeloma Patients.
Chamoun K, Firoozmand A, Caimi P, Fu P, Cao S, Otegbeye F, Metheny L, Patel S, Gerson SL, Boughan K, De Lima M, Malek E. Chamoun K, et al. Among authors: otegbeye f. Cancers (Basel). 2021 Feb 3;13(4):590. doi: 10.3390/cancers13040590. Cancers (Basel). 2021. PMID: 33546206 Free PMC article.
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies.
Woost PG, William BM, Cooper BW, Ueda Oshima M, Otegbeye F, De Lima MJ, Wald D, Mahfouz RZ, Saunthararajah Y, Stefan T, Jacobberger JW. Woost PG, et al. Among authors: otegbeye f. Cytometry B Clin Cytom. 2024 Jan;106(1):11-24. doi: 10.1002/cyto.b.22158. Epub 2024 Feb 12. Cytometry B Clin Cytom. 2024. PMID: 38345160
Inhibition of 15-PGDH Protects Mice from Immune-Mediated Bone Marrow Failure.
Smith JNP, Otegbeye F, Jogasuria AP, Christo KF, Antczak MI, Ready JM, Gerson SL, Markowitz SD, Desai AB. Smith JNP, et al. Among authors: otegbeye f. Biol Blood Marrow Transplant. 2020 Aug;26(8):1552-1556. doi: 10.1016/j.bbmt.2020.04.010. Epub 2020 May 15. Biol Blood Marrow Transplant. 2020. PMID: 32422251 Free PMC article.
History of drug use in allogeneic hematopoietic cell transplant recipients.
Abou-Ismail MY, Ravi G, Fu P, Cao S, Vuyyala S, Caimi P, Kolk M, Ferrari N, Boughan K, Cooper B, Gallogly M, Otegbeye F, Tomlinson B, de Lima M, Metheny L. Abou-Ismail MY, et al. Among authors: otegbeye f. Bone Marrow Transplant. 2021 Mar;56(3):581-585. doi: 10.1038/s41409-020-01058-z. Epub 2020 Sep 17. Bone Marrow Transplant. 2021. PMID: 32943757
Targeted Marrow Irradiation Intensification of Reduced-Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation.
Ali N, Sharma AA, de Rezende ACP, Otegbeye F, Latif BM, Kerbauy MN, Cooper BW, Sanchez G, Metheny L, Bal SK, Sakuraba R, Tomlinson BK, Boughan KM, Kerbauy L, Malek E, Ribeiro AF, Gallogly M, Mansur D, Pereira G, Weltman E, Sekaly RP, de Lima M, Caimi PF, Hamerschlak N. Ali N, et al. Among authors: otegbeye f. Transplant Cell Ther. 2022 Jul;28(7):370.e1-370.e10. doi: 10.1016/j.jtct.2022.04.001. Epub 2022 Apr 11. Transplant Cell Ther. 2022. PMID: 35421620 Free article. Clinical Trial.
31 results